What is the current valuation of the US ophthalmic viscoelastic devices market?

The market valuation was 521.85 USD Million in 2024. Read More

What is the projected market size for the US ophthalmic viscoelastic devices market by 2035?

The market is projected to reach 891.8 USD Million by 2035. Read More

What is the expected CAGR for the US ophthalmic viscoelastic devices market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 4.99%. Read More

Which application segment had the highest valuation in 2024?

Cataract surgery had the highest valuation at 353.12 USD Million in 2024. Read More

What are the key product types in the US ophthalmic viscoelastic devices market?

Key product types include Sodium Hyaluronate, Chondroitin Sulfate, and Hydroxypropyl Methylcellulose. Read More

Which distribution channel is projected to perform best by 2035?

The distributor channel is likely to perform best, with a valuation of 353.12 USD Million in 2024. Read More

What is the market performance of ambulatory surgical centers in 2024?

Ambulatory surgical centers had a market valuation of 263.52 USD Million in 2024. Read More

Who are the leading companies in the US ophthalmic viscoelastic devices market?

Key players include Alcon, Abbott, Bausch + Lomb, and Johnson & Johnson. Read More

What is the valuation of the corneal surgery segment in 2024?

The corneal surgery segment was valued at 132.12 USD Million in 2024. Read More

How does the market for high molecular weight viscoelastic devices compare to low molecular weight devices?

High molecular weight devices had a valuation of 350.0 USD Million, surpassing low molecular weight devices at 250.0 USD Million in 2024. Read More

US Ophthalmic Viscoelastic devices Market

ID: MRFR/MED/18448-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Ophthalmic Viscoelastic Devices Market Research Report: Size, Share, Trend Analysis By Types (Cohesive OVDs, Dispersive OVDs), By Applications (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery) and By End Users (Ophthalmic Clinics & Phaco Centers, Hospitals, Academic & Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

US Ophthalmic Viscoelastic devices Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Cataract Surgery
  2. 4.1.2 Glaucoma Surgery
  3. 4.1.3 Corneal Surgery
  4. 4.1.4 Retinal Surgery
2. 4.2 Healthcare, BY End Use (USD Million)
  1. 4.2.1 Hospitals
  2. 4.2.2 Ambulatory Surgical Centers
  3. 4.2.3 Ophthalmology Clinics
3. 4.3 Healthcare, BY Product Type (USD Million)
  1. 4.3.1 Sodium Hyaluronate
  2. 4.3.2 Chondroitin Sulfate
  3. 4.3.3 Hydroxypropyl Methylcellulose
  4. 4.3.4 Other Viscoelastic Devices
4. 4.4 Healthcare, BY Formulation (USD Million)
  1. 4.4.1 High Molecular Weight
  2. 4.4.2 Low Molecular Weight
  3. 4.4.3 Combination Formulations
5. 4.5 Healthcare, BY Distribution Channel (USD Million)
  1. 4.5.1 Direct Sales
  2. 4.5.2 Distributors
  3. 4.5.3 Online Sales
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Alcon (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bausch + Lomb (CA)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Carl Zeiss (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hoya Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Santen Pharmaceutical (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck & Co. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Eyevance Pharmaceuticals (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY END USE
4. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
5. 6.5 US MARKET ANALYSIS BY FORMULATION
6. 6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  2. 7.2.2 BY END USE, 2026-2035 (USD Million)
  3. 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
  4. 7.2.4 BY FORMULATION, 2026-2035 (USD Million)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

Cataract Surgery
Glaucoma Surgery
Corneal Surgery
Retinal Surgery

Healthcare By End Use (USD Million, 2026-2035)

Hospitals
Ambulatory Surgical Centers
Ophthalmology Clinics

Healthcare By Product Type (USD Million, 2026-2035)

Sodium Hyaluronate
Chondroitin Sulfate
Hydroxypropyl Methylcellulose
Other Viscoelastic Devices

Healthcare By Formulation (USD Million, 2026-2035)

High Molecular Weight
Low Molecular Weight
Combination Formulations

Healthcare By Distribution Channel (USD Million, 2026-2035)

Direct Sales
Distributors
Online Sales

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”